Wider View: PacBio looks to faster growth, but not yet neck-to-neck with Illumina
Omniome doesn’t have any products on the market yet, but Pacbio believes its proprietary short-read sequencing technology will be a springboard into a much bigger, multi-billion-dol...
ml.firstwordhealthtech.com